Wes Streeting, the secretary for Health and Social Care, must find funding for research Into invasive lobular breast cancer - to save lives and end an injustice towards women. The Ecologist is an ...

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the potential of BGB-B2033 in an area of high unmet need ...

TORONTO, Dec. 23, 2025 /CNW/ - BeOne Medicines, a global oncology company, today announced that Health Canada has granted a Notice of Compliance (NOC), approving TEVIMBRA® (tislelizumab for injection) ...

It's a rare occasion when my worlds of biomedical informatics and serialized lesbian melodrama fandom collide. But that's exactly what happened earlier this summer when two of my favorite actresses ...